AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Oostrom, A. J
Right arrow Articles by Castro Cabezas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Oostrom, A. J
Right arrow Articles by Castro Cabezas, M.
Agricola
Right arrow Articles by van Oostrom, A. J
Right arrow Articles by Castro Cabezas, M.
American Journal of Clinical Nutrition, Vol. 79, No. 3, 510-515, March 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 31,2,3

Antonie J van Oostrom, Hans van Dijk, Caroline Verseyden, Allan D Sniderman, Katherine Cianflone, Ton J Rabelink and Manuel Castro Cabezas

1 From the Department of Vascular Medicine (AJvO, CV, TJR, and MCC) and the Eijkman-Winkler Institute for Medical Microbiology, Infectious Diseases, and Inflammation (HvD), University Medical Center Utrecht, Utrecht, Netherlands, and the Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University, Montreal (ADS and KC)

Background: Elevated fasting plasma concentrations of complement component 3 (C3) are associated with elevated fasting and postprandial triacylglycerol concentrations, insulin resistance, obesity, and coronary artery disease. C3 is the central component of the complement system and the precursor of acylation-stimulating protein (ASP). Insulin and ASP are principal determinants of free fatty acid (FFA) trapping by adipose tissue.

Objective: Because controversy exists concerning postprandial changes in C3 and because meal composition may influence complement activation, we studied postprandial lipemia in relation to changes in plasma C3.

Design: After an overnight fast, 6 healthy men ( ± SD age: 23 ± 2 y) underwent 4 oral liquid challenges: fat (50 g/m2 body surface), glucose (37.5 g/m2), fat and glucose (mixed test), and water (as a control test) in a random, crossover design.

Results: Plasma ASP concentrations did not change postprandially in any test. Changes in C3 concentration were observed only after the fat challenge: elevated concentrations occurred between 1 and 3 h, and a maximum increase of 11% occurred at 2 h (P = 0.05). Postprandial triacylglycerolemia did not differ significantly between the fat and mixed tests. The FFA response after the fat challenge was the highest of all the tests (P < 0.05 for all comparisons) and was accompanied by an increase in ketone bodies (maximum at 6 h); this increase did not occur after the mixed test, which suggests less hepatic FFA delivery.

Conclusions: When glucose is added to an oral fat load, the postprandial FFA response is reduced, and the fat-specific increase in C3 is prevented. After ingestion of fat without glucose, the lack of insulin response may lead to C3-mediated peripheral FFA trapping, which probably serves as a backup system in case of insufficient or inefficient insulin-dependent FFA trapping.

Key Words: Complement component 3 • free fatty acids • insulin • triacylglycerol • acylation-stimulating protein • healthy men




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. P. Kinman, T. Kasumov, K. A. Jobbins, K. R. Thomas, J. E. Adams, L. N. Brunengraber, G. Kutz, W.-U. Brewer, C. R. Roe, and H. Brunengraber
Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E860 - E866.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. P. H. van Wijk, M. C. Cabezas, E. J. P. de Koning, T. J. Rabelink, R. van der Geest, and I. M. Hoepelman
In Vivo Evidence of Impaired Peripheral Fatty Acid Trapping in Patients with Human Immunodeficiency Virus-Associated Lipodystrophy
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3575 - 3582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition